Host intestinal immune system and mucosal barrier

The host intestinal immune system and mucosal barrier constitute a sophisticated multi-layered defense mechanism essential for maintaining systemic homeostasis and preventing the entry of pathogens and toxins from the gut lumen (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266987/). This system includes a physical barrier formed by the intestinal epithelium and tight junction proteins, a chemical barrier of antimicrobial peptides and secretory IgA, and a specialized immune network known as the gut-associated lymphoid tissue (GALT) (https://www.nature.com/articles/nri.2017.106). Dysregulation of this barrier, often referred to as "leaky gut," is implicated in the pathogenesis of inflammatory bowel diseases (IBD), celiac disease, and various metabolic disorders (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790068/). Therapeutic interventions often target specific components within this system, such as TNF-alpha or integrins, to reduce inflammation or enhance barrier repair (https://pubmed.ncbi.nlm.nih.gov/28521155/). Maintaining the balance between immune surveillance and tolerance is critical, as excessive responses can lead to chronic tissue damage and systemic inflammation. Because it encompasses a wide array of cells and proteins rather than a single molecule, it is classified as a biological system rather than a discrete therapeutic target.

Other names

Gut mucosal barrierIntestinal barrierGut-associated lymphoid tissueGALTIntestinal immune system

Modulation of inflammatory cytokines, inhibition of leukocyte trafficking, and reinforcement of epithelial barrier integrity.